According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
A diversity of the clinical manifestations of systemic lupus erythematosus (SLE) and its undulating course with alternating remissions and exacerbations make this disease one of the most difficult ones to diagnose, treat, and evaluate the efficiency of therapy.Despite the fact that the recently deve...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2019-11-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2782 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849687881264660480 |
|---|---|
| author | T. V. Popkova T. A. Panafidina S. K. Solovyev |
| author_facet | T. V. Popkova T. A. Panafidina S. K. Solovyev |
| author_sort | T. V. Popkova |
| collection | DOAJ |
| description | A diversity of the clinical manifestations of systemic lupus erythematosus (SLE) and its undulating course with alternating remissions and exacerbations make this disease one of the most difficult ones to diagnose, treat, and evaluate the efficiency of therapy.Despite the fact that the recently developed methods for early diagnosis and procedures for combined pathogenetic therapy and monitoring the disease course have led to increases in survival rates (≥90%) and life expectancy in patients with SLE, there are still many unsolved problems. In particular, the treatment for SLE is not yet efficient enough and the activity of the latter cannot be completely controlled. The relapsing and remitting course of SLE concurrent with comorbidity, as well as the adverse effects of glucocorticoids and immunosuppressants contribute to the accumulation of irreversible organ damages.The paper is devoted to a review of the updated EULAR recommendations for the treatment of systemic lupus erythematosus, which were published in 2019. It presents comments and debatable issues, by taking into account the Russian recommendations for the treatment of SLE. |
| format | Article |
| id | doaj-art-a440292f952e4392bfa4eac6a26e471e |
| institution | DOAJ |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2019-11-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-a440292f952e4392bfa4eac6a26e471e2025-08-20T03:22:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922019-11-0157549651010.14412/1995-4484-2019-496-5102534According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and commentsT. V. Popkova0T. A. Panafidina1S. K. Solovyev2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyA diversity of the clinical manifestations of systemic lupus erythematosus (SLE) and its undulating course with alternating remissions and exacerbations make this disease one of the most difficult ones to diagnose, treat, and evaluate the efficiency of therapy.Despite the fact that the recently developed methods for early diagnosis and procedures for combined pathogenetic therapy and monitoring the disease course have led to increases in survival rates (≥90%) and life expectancy in patients with SLE, there are still many unsolved problems. In particular, the treatment for SLE is not yet efficient enough and the activity of the latter cannot be completely controlled. The relapsing and remitting course of SLE concurrent with comorbidity, as well as the adverse effects of glucocorticoids and immunosuppressants contribute to the accumulation of irreversible organ damages.The paper is devoted to a review of the updated EULAR recommendations for the treatment of systemic lupus erythematosus, which were published in 2019. It presents comments and debatable issues, by taking into account the Russian recommendations for the treatment of SLE.https://rsp.mediar-press.net/rsp/article/view/2782systemic lupus erythematosustreatmentrecommendationseuropean league against rheumatism (eular) |
| spellingShingle | T. V. Popkova T. A. Panafidina S. K. Solovyev According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments Научно-практическая ревматология systemic lupus erythematosus treatment recommendations european league against rheumatism (eular) |
| title | According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments |
| title_full | According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments |
| title_fullStr | According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments |
| title_full_unstemmed | According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments |
| title_short | According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments |
| title_sort | according to the 2019 updated european league against rheumatism eular recommendations for the treatment of systemic lupus erythematosus debatable issues and comments |
| topic | systemic lupus erythematosus treatment recommendations european league against rheumatism (eular) |
| url | https://rsp.mediar-press.net/rsp/article/view/2782 |
| work_keys_str_mv | AT tvpopkova accordingtothe2019updatedeuropeanleagueagainstrheumatismeularrecommendationsforthetreatmentofsystemiclupuserythematosusdebatableissuesandcomments AT tapanafidina accordingtothe2019updatedeuropeanleagueagainstrheumatismeularrecommendationsforthetreatmentofsystemiclupuserythematosusdebatableissuesandcomments AT sksolovyev accordingtothe2019updatedeuropeanleagueagainstrheumatismeularrecommendationsforthetreatmentofsystemiclupuserythematosusdebatableissuesandcomments |